Compare ARPA (ARPA) vs Enzyme (MLN) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARPA vs Enzyme — how do they compare? ARPA trades at Rp158.96 (market cap Rp243,05M, Rp338,54M 24h volume), while Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume). The key difference: ARPA is the larger of the two by market cap, and ARPA's circulating supply is 1,5B ARPA versus 3,3M MLN for Enzyme. Which is the better fit depends on your goals — on Pluang, investors hold ARPA for 40 Days and Enzyme for 28 Days on average.
| ARPA | MLN | |
|---|---|---|
Market Cap | Rp243,05M | Rp134,13M |
Volume (24h) | Rp338,54M | Rp104,56M |
Circulating Supply | 1,5B ARPA | 3,3M MLN |
Typical Hold Time | 40 Days | 28 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARPA is trading at Rp155.55 with a market cap of Rp237.75 million, showing mixed technical signals—bearish moving averages but bullish oscillators. The price hovers near the pivot point of Rp159, with support at Rp148 and resistance at Rp165. No major protocol updates or ecosystem developments were noted recently. Trading volume and network activity remain modest, with a hold time of 40 days indicating moderate investor retention.
Overall outlook is cautious due to conflicting indicators and limited fundamental catalysts. Key opportunities include potential rebounds from support levels, while risks involve low liquidity and bearish trend pressure. Investors should monitor for any ecosystem updates or volume spikes that could shift momentum.
Enzyme (MLN) shows limited market activity with a modest market cap of Rp134.13 million and circulating supply of 3.3 million tokens. The asset demonstrates relatively low volatility with a 28-day average hold time, suggesting stable holding patterns among current investors. Trading volumes appear subdued, indicating limited market participation and liquidity depth at current levels.
Overall outlook remains cautious due to thin liquidity and limited ecosystem developments. Key opportunities include potential protocol upgrades and ecosystem expansion, while major risks center around low trading volumes and regulatory uncertainty in the cryptocurrency space. Investors should monitor network activity and exchange listings for catalysts.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About ARPA
ARPA Network (ARPA) is a decentralized secure computation network built to improve the fairness, security, and privacy of blockchains. ARPA threshold BLS signature network serves as the infrastructure of verifiable Random Number Generator (RNG), secure wallet, cross-chain bridge and decentralized custody across multiple blockchains. ARPA was previously known as ARPA Chain, a privacy-preserving Multi-party Computation (MPC) network founded in 2018. ARPA Mainnet has completed over 224,000 computation tasks in the past years.
Read more on ARPA →About Enzyme
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →
